BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160; SSE: 688235), a global oncology company, today announced it will share research from studies evaluating BRUKINSA® (zanubrutinib), Bruton tyrosine kinase (BTK) ...
As such I provide here a small sample of quotes – some newer, some a bit older – by various experts on the topic. And lest it seem that I am just another redneck racist, the first four authors quoted ...